Jan. 15 2008
Source Page: Table showing count of finished admission episodes where there was a primary or secondary diagnosis of alcoholic liver disease and alcoholic cirrhosis of the liver by gender and age for a) the East of England Strategic Health Authority in 2006/07 b) Southend on Sea Primary Care Trust 1997/98 - 2005/06 and c) South East Essex Primary Care Trust in 2006/07. 6 p.Found: count of finished admission episodes where there was a primary or secondary diagnosis of alcoholic liver
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the effectiveness of (a) community liver health checks, (b) primary care pilots and (c) surveillance for hepatocellular carcinoma as part of NHS England's early detection of liver cancer programme.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The care of and treatment for patients with cancers, including liver cancer, is a priority for the Government. National Health Service cancer standards have been reformed with the support of clinicians to speed up diagnosis for patients, which means people will receive a diagnosis or have cancer ruled out within 28 days from urgent cancer referral from their general practice. NHS England’s Early diagnosis of Liver Cancer Programme is contributing to deliver the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.
Mentions:
1: Navendu Mishra (Lab - Stockport) I beg to move,That this House has considered health inequalities in liver disease and liver cancer.It - Speech Link
2: Alison Thewliss (SNP - Glasgow Central) There is a real stigma around liver issues, which we must do our best to bust.We have a public health - Speech Link
3: Alison Thewliss (SNP - Glasgow Central) disease and liver cancer; we can prevent that progression if the public health imperative is there. - Speech Link
Oct. 12 2009
Source Page: Table showing the number of finished hospital admission episodes for the East of England with a primary diagnosis of (a) alcoholic liver disease and (b) cirrhosis of the liver from 1999/00 to 2007/08. 11 p.Found: finished hospital admission episodes for the East of England with a primary diagnosis of (a) alcoholic liver
Found: Health inequalities in liver disease and liver cancer
Written Evidence May. 24 2024
Inquiry: Food, Diet and ObesityFound: Tees Hospitals NHS Foundation Trust Middlesborough, UK Professor Leah Avery, Professor of Applied Health
Apr. 08 2024
Source Page: Liver disease profile, April 2024 updateFound: Liver disease profile, April 2024 update
Asked by: Gregory Campbell (Democratic Unionist Party - East Londonderry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has made an estimate of expected liver cancer mortality rates by the end of 2025.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
No estimate has been made of expected liver cancer mortality rates by the end of 2025. The care of and treatment for patients with cancer, including liver cancer, is a priority for the Government. Early diagnosis of liver cancer is critical to improving rates of survival. NHS England’s Early Diagnosis of Liver Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. This programme includes three workstreams: improving liver surveillance programmes; community liver health checks pilots; and primary care pilots. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.
Asked by: Sharon Hodgson (Labour - Washington and Sunderland West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to support the detection of liver disease in Washington and Sunderland West constituency.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Northern Cancer Alliance (NCA) is supporting services to enable the early detection of liver disease across the North East and North Cumbria (NENC) Integrated Care Board (ICB), including in the Washington and Sunderland West Constituency. The focus of work has been to support liver services across NENC to invite more than 80% of patients with cirrhosis, a type of liver disease, to monthly ultrasound surveillance. For 2024/25, the NCA has invested just over £200,000 into trusts across NENC to help improve their monitoring systems for cirrhosis patients.
The NENC ICB is also enrolled in a Community Liver Health Check pilot in Newcastle, being delivered by the system’s Hepatitis C Operational Delivery Networks. This will provide FibroScans in one stop community clinics where patients have relevant blood testing, liver ultrasound, and other investigations, as required. The pilot has expanded into North Tyneside and when resources allow, they intend to develop additional clinics across the area.
Asked by: Alison Thewliss (Scottish National Party - Glasgow Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment of the implications for her policies of the development of intelligent liver function tests by the University of Dundee; and if she will make it her policy to increase the rollout of these tests in areas with the highest levels of liver disease in England.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government is working with the National Health Service to support earlier diagnosis of liver disease, and to identify patients at risk. This includes plans agreed as part of the £2.3 billion diagnostics transformation programme, to upgrade the digital capabilities of laboratories across the country and ensure that they have the capability required to offer Intelligent Liver Function Tests (iLFTs).
NHS England is reviewing the liver fibrosis pathways, and looking at developing a diagnosis pathway starting in primary care that will make use of both laboratory-based tests, such as iLFTs, and community diagnostic centres. The Government will make a further assessment of this work once it is complete, including the benefits of an increased rollout of iLFTs across England.